跳至主要内容
临床试验/NL-OMON26240
NL-OMON26240招募中不适用

A multicenter, prospective feasibility follow-up study to evaluate a fully covered stent with new antimigration properties for the palliation of malignant dysphagia: HANARO study.

niversity Medical Center Utrecht (UMCU), Departement of Gastronenterology and Hepatology0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
40

研究概览

简要总结

/A

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Inoperable malignant obstruction of the esophagus or esophagogastric junction caused by esophageal or cardia carcinoma or extrinsic malignant compression. A tumor is considered inoperable if the patient has local tumor infiltration in the surrounding organs, distant metastases or a poor general health due to serious concomitant disease, OR;
  • 2. Recurrent dysphagia after prior radiation with curative or palliative intent for esophageal or gastric cardia cancer;

排除标准

  • 1. Evidence of tumor growth within 2 cm of the upper esophageal sphincter;
  • 2. A tumor covering < 50% of the circumference;

研究者

发起方
niversity Medical Center Utrecht (UMCU), Departement of Gastronenterology and Hepatology

相似试验